The Spectranetics Corp (SPNC) 23.76 $SPNC
Spectranetics TightRail(TM) Rotating Dilator Sheath Achieves Clinical Goal in First In-patient Case
GlobeNewswire - Wed May 07, 4:49PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) announced successful completion of the first live case using the TightRail(TM) Rotating Dilator Sheath performed by Charles Love, MD. On the heels of FDA clearance in April, the procedure represents a significant milestone as the company readies the TightRail tool for full launch later this month.
Spectranetics Shares Down 25.5% Since SmarTrend's Sell Call (SPNC)
Comtex SmarTrend(R) - Wed May 07, 9:46AM CDT
SmarTrend identified a Downtrend for Spectranetics (NASDAQ:SPNC) on April 4th, 2014 at $28.27. In approximately 1 month, Spectranetics has returned 25.54% as of today's recent price of $21.05.
Spectranetics Debuts Next-generation Mechanical Extraction Devices at Heart Rhythm 2014
GlobeNewswire - Mon May 05, 11:44PM CDT
May 7 through 10, 2014, Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions, convenes in San Francisco, Calif. The Spectranetics Corporation (NASDAQ: SPNC), headquartered in Colorado Springs, Colo., will focus on management of cardiac device infections and debut of the company's first mechanical lead extraction devices.
Weakness Seen in The Spectranetics Corporation (SPNC) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:44AM CDT
The Spectranetics Corporation has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Spectranetics Achieves First Quarter 2014 Revenue of $39.6 Million
GlobeNewswire - Wed Apr 23, 3:03PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today reported financial results for the three months ended March 31, 2014, which are in-line with preliminary results announced on April 7, 2014. Highlights of the quarter, all compared with the three months ended March 31, 2013 include:
Organizational Transitions, Patient Enrollment, Initiation of Clinical Programs, Financial Outlook, and Corporate Updates - Analyst Notes on Insmed, Akebia, Retrophin, Agios and Spectranetics
PR Newswire - Wed Apr 23, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Insmed Incorporated (NASDAQ: INSM), Akebia Therapeutics, Inc. (NASDAQ: AKBA), Retrophin, Inc. (NASDAQ: RTRX), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) and The Spectranetics Corporation (NASDAQ: SPNC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1455-100free.
Spectranetics Has Returned 11.8% Since SmarTrend Recommendation (SPNC)
Comtex SmarTrend(R) - Tue Apr 22, 5:21PM CDT
SmarTrend identified a Downtrend for Spectranetics (NASDAQ:SPNC) on April 4th, 2014 at $28.27. In approximately 3 weeks, Spectranetics has returned 11.83% as of today's recent price of $24.92.
'Fast Money' Recap: Following the Netflix Story
at The Street - Tue Apr 22, 4:00AM CDT
The trading panel discussed Netflix earnings and Valeant's hostile bid for Allergan.
Earnings Release Dates -- Research on Spectranetics, Aspen Insurance Holdings, Evercore Partners, and Everest Re Group
PR Newswire - Mon Apr 21, 8:00AM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Spectranetics Corp. (NASDAQ: SPNC), Aspen Insurance Holdings Ltd (NYSE: AHL), Evercore Partners Inc. (NYSE: EVR) and Everest Re Group Ltd (NYSE: RE). Full earnings notes on SPNC, AHL, EVR and RE can be downloaded upon signing up at:
J&J Earnings Beat Estimates As Pharma Sales Shine
at Investor's Business Daily - Tue Apr 15, 10:17AM CDT
Johnson & Johnson (JNJ) kicked off the medical industry's Q1 earnings season with a modest upside surprise Tuesday, sending the stock up 1.5% in morning trading on the stock market today. J&J's earnings, minus one-time items, totaled $1.54 a share,...
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Commit To Buy Spectranetics At $20, Earn 9.6% Annualized Using Options
at The Street - Fri Apr 11, 10:37AM CDT
Investors considering a purchase of Spectranetics Corp. shares, but cautious about paying the going market price of $24.01/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Acquisitions, Scheduled Earnings Releases, Appointments, Clinical Trials, and Stock Movements - Analyst Notes on Baxter, AcelRx, Synta Pharmaceuticals, Spectranetics, and NuVasive
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Baxter International Inc. (NYSE: BAX), AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), Synta Pharmaceuticals Corp. (NASDAQ: SNTA), The Spectranetics Corporation (NASDAQ: SPNC), and NuVasive, Inc. (NASDAQ: NUVA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Spectranetics Announces FDA Clearance for Mechanical Lead Extraction Devices
GlobeNewswire - Thu Apr 10, 3:35PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced FDA clearance of two new mechanical lead extraction platforms that expand physicians' options for safe removal of cardiac leads. Each incorporates innovative designs for mechanical extraction aimed at providing total lead management solutions.
Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 08, 5:29PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Spectranetics (SPNC) Stock Is Plummeting Today
at The Street - Tue Apr 08, 1:05PM CDT
Spectranetics (SPNC) shares are down -11.6% to $23.08 in trading on Tuesday.
Spectranetics Announces Preliminary Results for First Quarter 2014 and Updates 2014 Guidance
GlobeNewswire - Mon Apr 07, 3:02PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced preliminary results for the three months ended March 31, 2014. The company will provide a full report on the financial results for the first quarter of 2014, and conduct a conference call with investors, on April 23, 2014. Spectranetics expects to report the following results for its first quarter of 2014, all compared with the three months ended March 31, 2013:
Spectranetics Up 77.6% Since SmarTrend Uptrend Call (SPNC)
Comtex SmarTrend(R) - Tue Apr 01, 9:37AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on October 2nd, 2013 at $17.34. In approximately 6 months, Spectranetics has returned 77.62% as of today's recent price of $30.79.
Spectranetics TightRail(TM) Rotating Dilator Sheath Achieves Clinical Goal in First In-patient Case
GlobeNewswire - Wed May 07, 4:49PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) announced successful completion of the first live case using the TightRail(TM) Rotating Dilator Sheath performed by Charles Love, MD. On the heels of FDA clearance in April, the procedure represents a significant milestone as the company readies the TightRail tool for full launch later this month.
Spectranetics Shares Down 25.5% Since SmarTrend's Sell Call (SPNC)
Comtex SmarTrend(R) - Wed May 07, 9:46AM CDT
SmarTrend identified a Downtrend for Spectranetics (NASDAQ:SPNC) on April 4th, 2014 at $28.27. In approximately 1 month, Spectranetics has returned 25.54% as of today's recent price of $21.05.
Spectranetics Debuts Next-generation Mechanical Extraction Devices at Heart Rhythm 2014
GlobeNewswire - Mon May 05, 11:44PM CDT
May 7 through 10, 2014, Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions, convenes in San Francisco, Calif. The Spectranetics Corporation (NASDAQ: SPNC), headquartered in Colorado Springs, Colo., will focus on management of cardiac device infections and debut of the company's first mechanical lead extraction devices.
Weakness Seen in The Spectranetics Corporation (SPNC) Estimates: Should You Stay Away? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 02, 7:44AM CDT
The Spectranetics Corporation has seen negative earnings estimate revisions for the current quarter along with a significant decline in its share price for the past month
Spectranetics Achieves First Quarter 2014 Revenue of $39.6 Million
GlobeNewswire - Wed Apr 23, 3:03PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today reported financial results for the three months ended March 31, 2014, which are in-line with preliminary results announced on April 7, 2014. Highlights of the quarter, all compared with the three months ended March 31, 2013 include:
Organizational Transitions, Patient Enrollment, Initiation of Clinical Programs, Financial Outlook, and Corporate Updates - Analyst Notes on Insmed, Akebia, Retrophin, Agios and Spectranetics
PR Newswire - Wed Apr 23, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Insmed Incorporated (NASDAQ: INSM), Akebia Therapeutics, Inc. (NASDAQ: AKBA), Retrophin, Inc. (NASDAQ: RTRX), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) and The Spectranetics Corporation (NASDAQ: SPNC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1455-100free.
Spectranetics Has Returned 11.8% Since SmarTrend Recommendation (SPNC)
Comtex SmarTrend(R) - Tue Apr 22, 5:21PM CDT
SmarTrend identified a Downtrend for Spectranetics (NASDAQ:SPNC) on April 4th, 2014 at $28.27. In approximately 3 weeks, Spectranetics has returned 11.83% as of today's recent price of $24.92.
'Fast Money' Recap: Following the Netflix Story
at The Street - Tue Apr 22, 4:00AM CDT
The trading panel discussed Netflix earnings and Valeant's hostile bid for Allergan.
Earnings Release Dates -- Research on Spectranetics, Aspen Insurance Holdings, Evercore Partners, and Everest Re Group
PR Newswire - Mon Apr 21, 8:00AM CDT
Earningsource.com provides investors with earnings schedule updates throughout the earnings season. With timely information on past earnings performance and earnings projection for their upcoming quarterly release, our aim is to ensure shareholders and traders have an edge on their investment decisions on the following companies: Spectranetics Corp. (NASDAQ: SPNC), Aspen Insurance Holdings Ltd (NYSE: AHL), Evercore Partners Inc. (NYSE: EVR) and Everest Re Group Ltd (NYSE: RE). Full earnings notes on SPNC, AHL, EVR and RE can be downloaded upon signing up at:
J&J Earnings Beat Estimates As Pharma Sales Shine
at Investor's Business Daily - Tue Apr 15, 10:17AM CDT
Johnson & Johnson (JNJ) kicked off the medical industry's Q1 earnings season with a modest upside surprise Tuesday, sending the stock up 1.5% in morning trading on the stock market today. J&J's earnings, minus one-time items, totaled $1.54 a share,...
Health Care Sector Equities Update -- Research on Endologix, Align Technology, Spectranetics, and Unilife
PR Newswire - Mon Apr 14, 8:00AM CDT
The trading session on Friday, April 11, 2014 ended on a lower note as the Dow Jones Industrial Average finished at 16,026.75, down 0.89% and the NASDAQ Composite closed at 3,999.73, down 1.34%. The S&P 500 finished the session 0.95% lower at 1,815.69. The losses were broad based as all the ten sectors posted losses. The S&P 500 Health Care Sector Index finished the day at 644.74, down 1.07%, and the same has declined 2.36% in last three months. Investor-Edge has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Align Technology Inc. (NASDAQ: ALGN), Spectranetics Corp. (NASDAQ: SPNC) and Unilife Corp. (NASDAQ: UNIS). Free technical research on ELGX, ALGN, SPNC and UNIS can be downloaded upon signing up at:
Commit To Buy Spectranetics At $20, Earn 9.6% Annualized Using Options
at The Street - Fri Apr 11, 10:37AM CDT
Investors considering a purchase of Spectranetics Corp. shares, but cautious about paying the going market price of $24.01/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Acquisitions, Scheduled Earnings Releases, Appointments, Clinical Trials, and Stock Movements - Analyst Notes on Baxter, AcelRx, Synta Pharmaceuticals, Spectranetics, and NuVasive
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Baxter International Inc. (NYSE: BAX), AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), Synta Pharmaceuticals Corp. (NASDAQ: SNTA), The Spectranetics Corporation (NASDAQ: SPNC), and NuVasive, Inc. (NASDAQ: NUVA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Spectranetics Announces FDA Clearance for Mechanical Lead Extraction Devices
GlobeNewswire - Thu Apr 10, 3:35PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced FDA clearance of two new mechanical lead extraction platforms that expand physicians' options for safe removal of cardiac leads. Each incorporates innovative designs for mechanical extraction aimed at providing total lead management solutions.
Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 08, 5:29PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
Why Spectranetics (SPNC) Stock Is Plummeting Today
at The Street - Tue Apr 08, 1:05PM CDT
Spectranetics (SPNC) shares are down -11.6% to $23.08 in trading on Tuesday.
Spectranetics Announces Preliminary Results for First Quarter 2014 and Updates 2014 Guidance
GlobeNewswire - Mon Apr 07, 3:02PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced preliminary results for the three months ended March 31, 2014. The company will provide a full report on the financial results for the first quarter of 2014, and conduct a conference call with investors, on April 23, 2014. Spectranetics expects to report the following results for its first quarter of 2014, all compared with the three months ended March 31, 2013:
Spectranetics Up 77.6% Since SmarTrend Uptrend Call (SPNC)
Comtex SmarTrend(R) - Tue Apr 01, 9:37AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on October 2nd, 2013 at $17.34. In approximately 6 months, Spectranetics has returned 77.62% as of today's recent price of $30.79.
